Combination Products in the European Union

摘要

Achieving marketing approval for a pharmaceutical or a medical device in the EU is a complicated process, necessitating a working knowledge of a complicated regulatory framework. If these two types of products are combined in the same package then this complexity is compounded. This is a challenge that companies are increasingly facing as the market and opportunities for combination products, not just in the EU, but worldwide, continues to grow.